Axogen Inc (NAS:AXGN)
$ 14.1 -0.31 (-2.15%) Market Cap: 634.16 Mil Enterprise Value: 678.49 Mil PE Ratio: 0 PB Ratio: 6.38 GF Score: 78/100

AxoGen Inc at JPMorgan Healthcare Conference Transcript

Jan 16, 2020 / 06:30PM GMT
Release Date Price: $15.02 (+2.18%)
K. Gong
JP Morgan Chase & Co, Research Division - Analyst

Okay so to -- as one of the closing presentation in the conference. My name is Allen Gong. I'm here representing the medical supplies and devices team here at JPMorgan. It's my pleasure to introduce the President, Chairman and CEO of AxoGen. Karen Zaderej. The breakout will be in the Sussex room down the hall.

Karen Zaderej
AxoGen, Inc. - Chairman, President & CEO

Okay. Thank you very much. Nerve injuries affect patients every day in many different ways. It can be the mother who gets a cut working in the kitchen and loses sensation in her hand. It can be a teenager who has wisdom teeth extraction and because of an injury in that procedure, loses sensation in that part of the mouth. It can be a young man in a sports activity with a sports-related trauma that ultimately ends up in chronic pain due to a neuroma in the nerve or it can be associated with a woman who has breast cancer and has a mastectomy. And as a result of that ends up with no sensation in her reconstructed breast. These are all

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot